Red Light Therapy and Cancer Research

Red Light Therapy and Cancer: Can Light Reduce Side Effects Without Fueling Cancer?

Red Light Therapy and Cancer: Can Light Reduce Side Effects Without Fueling Cancer? Photobiomodulation (PBM), often called red light therapy or low-level laser therapy (LLLT), is becoming one of the most researched non-drug supportive therapies in oncology.

Unlike radiation therapy, PBM does not damage DNA or kill cancer cells. Instead, carefully selected wavelengths of red or near-infrared light stimulate cellular energy production, reduce inflammation, and accelerate tissue repair.

For cancer patients and survivors, the question isn’t simply whether red light therapy works.

The important questions are:

Is it safe?
What side effects can it treat?
Could it stimulate cancer growth?
What does the scientific evidence actually show?

I’m interested in therapies that improve quality of life while remaining evidence-based. Photobiomodulation is one of those therapies worth understanding.

I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.

I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.

Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.

Good luck,

David Emerson

Red Light Therapy Explained in 10 Minutes

What Is Photobiomodulation?

Photobiomodulation (PBM) uses red (approximately 630–700 nm) and near-infrared (approximately 800–900 nm)light to stimulate mitochondria inside cells.

Rather than heating tissue, PBM produces biochemical changes that may:

Increase ATP (cellular energy)
Reduce oxidative stress
Improve blood flow
Decrease inflammation
Promote tissue repair
Reduce pain
Support nerve healing

Because chemotherapy and radiation frequently damage healthy tissue through inflammation and oxidative injury, PBM has attracted increasing attention as a supportive cancer therapy.

What Cancer Side Effects Does PBM Help?

1. Oral Mucositis (Strongest Evidence)

The best evidence by far involves oral mucositis, one of the most painful complications of:

head and neck radiation
chemotherapy
stem cell transplantation

Multiple randomized clinical trials have shown PBM can:

reduce severe mouth sores
lessen pain
improve swallowing
decrease opioid use
reduce interruptions in cancer treatment

Because of this evidence, international oncology organizations now recommend PBM for selected patients receiving high-risk treatments.

2. Radiation Skin Injury

Radiation dermatitis affects many patients receiving radiation for:

breast cancer
head and neck cancer
anal cancer
skin cancers

Studies suggest PBM may:

reduce redness
improve wound healing
lessen skin pain
shorten recovery

Although protocols continue to evolve, evidence is encouraging.

3. Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) remains one of oncology’s most difficult side effects.

Early studies suggest PBM may improve:

numbness
tingling
burning pain
nerve recovery
hand function
balance

Current evidence is promising but not yet definitive, and larger randomized trials are still needed.

4. Lymphedema

Some studies suggest PBM may reduce:

swelling
fibrosis
pain
arm stiffness after breast cancer treatment

PBM appears to improve lymphatic drainage in selected patients, although it is generally used alongside compression therapy and exercise—not as a replacement.

5. Xerostomia (Dry Mouth)

After head and neck radiation, damaged salivary glands can dramatically reduce quality of life.

Emerging evidence suggests PBM may:

improve saliva production
decrease mouth discomfort
improve swallowing
improve speech

More research is underway.

6. Late Radiation Fibrosis

Months or years after radiation therapy, scar tissue may develop.

PBM has shown potential for improving:

tissue flexibility
neck mobility
pain
fibrosis

Evidence remains moderate but continues to grow.

Does Red Light Therapy Make Cancer Grow?

This is the question every patient asks.

The short answer:

Current clinical evidence says no—when PBM is used according to established oncology protocols.

Some laboratory studies using isolated cancer cells have reported increased cell growth under certain light conditions.

However:

Laboratory cells behave differently from tumors inside the human body
Animal studies have been inconsistent
Human clinical studies have not demonstrated increased cancer recurrence when guideline-based PBM protocols are used for supportive care

Large systematic reviews conclude that appropriately delivered PBM appears safe for managing cancer-treatment side effects.

Current Oncology Guidelines

Perhaps the strongest endorsement comes from international supportive-care organizations.

The MASCC/ISOO guidelines recommend specific PBM protocols for preventing oral mucositis in selected cancer populations.

Similarly, the World Association for Photobiomodulation Therapy (WALT) published expert recommendations supporting PBM for numerous treatment-related toxicities, including:

oral mucositis
radiation dermatitis
dysphagia
xerostomia
fibrosis
lymphedema
peripheral neuropathy
chronic graft-versus-host disease

These recommendations emphasize that PBM should be delivered using evidence-based treatment parameters rather than arbitrary consumer-device settings.

Can You Use a Home Red Light Device?

Consumer PBM devices are now widely available.

However, most oncology studies use:

specific wavelengths
carefully measured power output
precise treatment times
defined treatment schedules
clinician supervision

That means a consumer LED panel purchased online cannot automatically be assumed to reproduce results seen in clinical trials.

Patients undergoing active treatment should discuss PBM with:

their oncologist
radiation oncologist
oncology dentist (for oral mucositis)
physical therapist
lymphedema therapist

Potential Risks

PBM is generally considered very safe.

Possible concerns include:

improper dosing
eye exposure without protection
use directly over known active tumors without physician guidance
poor-quality commercial devices

Most published adverse effects are mild and uncommon.

My Perspective

One of the recurring themes on PeopleBeatingCancer is that supportive therapies deserve the same evidence-based scrutiny as conventional treatments.

Photobiomodulation is a good example.

It is not an alternative cancer treatment.

It is not a cure for cancer.

But it may reduce several of the most debilitating side effects of chemotherapy, radiation therapy, and stem cell transplantation.

Helping patients complete potentially life-saving treatment with less pain, fewer interruptions, and a better quality of life is a meaningful goal. As the evidence continues to grow, photobiomodulation appears likely to become an increasingly important part of integrative oncology.

Bottom Line

Photobiomodulation is one of the best-supported non-drug supportive therapies available in cancer care.

Current evidence suggests that PBM can:

Prevent oral mucositis
Reduce radiation skin injury
Improve wound healing
Help relieve dry mouth
Improve lymphedema
Potentially reduce chemotherapy-induced neuropathy
Improve the quality of life during and after treatment

Importantly, current clinical evidence does not indicate that properly administered PBM increases cancer recurrence or promotes tumor growth. Patients should still consult their oncology team before beginning treatment, particularly during active cancer therapy.

Research References

MASCC/ISOO Clinical Practice Guideline: Photobiomodulation for Oral Mucositis (Supportive Care in Cancer, 2019)
https://pubmed.ncbi.nlm.nih.gov/31286228/
WALT Position Paper: Photobiomodulation in Cancer Therapy-Induced Side Effects (2022)
https://pubmed.ncbi.nlm.nih.gov/36110957/
Safety and Efficacy of Photobiomodulation Therapy in Oncology: Systematic Review (Cancer Medicine, 2020)
https://pmc.ncbi.nlm.nih.gov/articles/PMC7666741/
MASCC/ISOO Mucositis Guidelines (Cancer, 2020)
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33100

Our Mission